Ugandensolide

Ugandensolide

SCHEMBL21025899

CC(=O)O[C@@H]1[C@@H](O)C2=C(C(=O)OC2)[C@@]2(C)CCCC(C)(C)[C@H]12

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.31
▸ CYP3A4 P08684 3/20 0.31
▸ TSHR P16473 2/20 0.31
▸ NFKB1 P19838 2/20 0.31
▸ GMNN O75496 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ PMP22 Q01453 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ NR1I2 O75469 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ ABCB1 P08183 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ SLC2A1 P11166 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ SCN1A P35498 1/20 0.31
▸ ADCY8 P40145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21026193 0.70 MAPK1 (0.38) MAPK1CYP3A4TSHRNFKB1GMNN
SCHEMBL21026189 0.64 MAPK1 (0.35) MAPK1CYP3A4TSHRNFKB1GMNN
SCHEMBL29707610 0.63 CYP3A4 (0.41) CYP3A4KMT2ACYP19A1
SCHEMBL14982984 0.61 CYP3A4 (0.37) MAPK1CYP3A4TSHRNFKB1CYP2D6
Cinnamosmolide SCHEMBL21025700 0.60 NFKB1 (0.43) MAPK1CYP3A4TSHRNFKB1GMNN
Cinnamosmolide SCHEMBL15557098 0.60 NFKB1 (0.43) MAPK1CYP3A4TSHRNFKB1GMNN
Cinnamosmolide SCHEMBL21025897 0.60 NFKB1 (0.43) MAPK1CYP3A4TSHRNFKB1GMNN
Cinnamosmolide SCHEMBL21025571 0.60 NFKB1 (0.43) MAPK1CYP3A4TSHRNFKB1GMNN
SCHEMBL7811925 0.59 CYP3A4 (0.33) MAPK1CYP3A4NFKB1KMT2ANR1H4
SCHEMBL3678939 0.58 PTPN2 (0.41) MAPK1CYP3A4TSHRNFKB1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190150437-A1 USE OF SESQUITERPENES AND THEIR ANALOGS AS GREEN INSECTICIDES FOR CONTROLLING DISEASE VECTORS AND PLANT PESTS OHIO STATE INNOVATION FOUNDATION 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190150437-A1 USE OF SESQUITERPENES AND THEIR ANALOGS AS GREEN INSECTICIDES FOR CONTROLLING DISEASE VECTORS AND PLANT PESTS NOTUM, DDT, CYP51A1 MAPK1 4776/4885CYP3A4 219/4885TSHR 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback